Voyager Therapeutics to Host Fourth Quarter and Full Year 2016 Financial Results Conference call
March 08 2017 - 10:00AM
Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene
therapy company developing life-changing treatments for severe
diseases of the central nervous system (CNS), today announced its
fourth quarter and full year 2016 financial results conference call
and live webcast scheduled for Wednesday, March 15, 2017 at 8:30
a.m. EDT.
The live call may be accessed by dialing (877)
851-3834 for domestic callers or +1 (631) 291-4595 for
international callers, and referencing conference ID number
83618016. A live audio webcast of the conference call will be
available online from the Investors & Media section of
Voyager’s website at www.voyagertherapeutics.com. The webcast
will be archived for 30 days.
About Voyager Therapeutics
Voyager Therapeutics is a clinical-stage gene
therapy company developing life-changing treatments for severe
diseases of the CNS. Voyager is committed to advancing the
field of AAV gene therapy through innovation and investment in
vector engineering and optimization, manufacturing and dosing and
delivery techniques. The Company’s pipeline focuses on severe
CNS diseases in need of effective new therapies, including advanced
Parkinson’s disease, a monogenic form of ALS, Friedreich’s ataxia,
Huntington’s disease, frontotemporal dementia, Alzheimer’s disease
and severe, chronic pain. Voyager has broad strategic
collaborations with Sanofi Genzyme, the specialty care global
business unit of Sanofi, and the University of Massachusetts
Medical School. Founded by scientific and clinical leaders in
the fields of AAV gene therapy, expressed RNA interference and
neuroscience, Voyager Therapeutics is headquartered in Cambridge,
Massachusetts. For more information, please visit
www.voyagertherapeutics.com. Follow Voyager on LinkedIn.
Investor Relations:
Matt Osborne
Head of Investor Relations & Corporate Communications
857-259-5353
mosborne@vygr.com
Media:
Josephine Butler
Pure Communications, Inc.
910-337-0707
jbutler@purecommunications.com
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Apr 2023 to Apr 2024